• Spearheaded the valuation for one of the largest ERP and business transformation program in company's history; influencing senior stakeholders and successfully securing $1.5Bn in funding for this new initiative• Lead financial governance for multiple large-scale projects across the globe, managing teams across North America, Europe, Latin America, and Asia Pacific regions• Evaluate and prioritize upcoming transformation initiatives to support portfolio decision-making, ensure long-term strategic alignment, and drive impactful business outcomes

• Served as the Supply Chain Finance business process owner and solution leader for the Medical Device sector; delivered an automated financial consolidation platform and a digital financial reporting solution• Orchestrated the transition of finance transactional activities across multiple countries to a global shared service model in a low cost location, achieving long-term operational savings

• Oversaw the FP&A and strategic planning for the end-to-end supply chain; supporting $12Bn in revenue, $2Bn in spending, 10 business units, over 30 manufacturing sites, 17,000+ employees, and 180+ finance associates• Appointed as a key member of the publicly announced Restructuring Initiative; providing strategic financial assessment and governance for 13 network projects that resulted in over $200MM in savings

• Optimized the sector's cash flow performance through the deployment of new inventory entitlement model and capital governance; resulting in the achievement of its financial target for the first time in five years• Facilitated the first sector-wide initiative for cost accounting and supply chain Metric standardization across 20 business units and over 60 manufacturing and sourcing locations

• Served as the interim Finance Director on the company’s Global Management Board, supporting worldwide end-to-end operations including commercial, manufacturing, and R&D• Led due diligence efforts for the acquisition and integration of Immunicon Corporation, seamlessly integrating key financial and manufacturing systems within six months of the acquisition

• Managed US Donor Screening and Immunohematology commercial activities: partnering with key leaders to analyze changing market conditions, develop promotional programs, and prepare sales projections• Key member of the contract negotiation team, providing pricing and profitability analytics that resulted in strategic wins: America Red Cross - 50% market share secured; new US government contract - first time in 12 years

• Supported the effort in the company’s Initial Public Offering, resulting in proceeds exceeding $70MM; oversaw the ongoing preparation of its quarterly Form 10-Q and 10-K filings• Contributed to the company's needs as a start-up, including financial reporting, general accounting, cost control analytics, and accounts payable and receivable management